What question did this study set out to answer?

To explore how incretin receptor agonists affect CPAP use, mortality, and hospitalization rates in adults with diabetes, obesity, and obstructive sleep apnea.

January 10, 2026JAMA Network Open0 citationsOpen Access

Incretin Receptor Agonists and CPAP Use in Adults With Diabetes, Obesity, and Obstructive Sleep Apnea

Q: What does this research mean for the field?

Incretin receptor agonists are associated with improved CPAP adherence in adults with diabetes, obesity, and obstructive sleep apnea. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

HTHuilin Tang BZBingyu Zhang YLYe Lu

Key Result

Incretin receptor agonists were associated with improved CPAP adherence in adults with diabetes, obesity, and obstructive sleep apnea.

Key Points

To explore how incretin receptor agonists affect CPAP use, mortality, and hospitalization rates in adults with diabetes, obesity, and obstructive sleep apnea.
Cohort study design
Sample included adults diagnosed with diabetes, obesity, and obstructive sleep apnea
Assessment of CPAP usage and its outcomes
Analysis of hospitalization and mortality rates
Positive association found between incretin receptor agonist use and CPAP adherence
Reduced mortality rates observed among those using incretin receptor agonists
Hospitalization rates were lower in participants using both incretin receptor agonists and CPAP

Structured PICO

Do incretin receptor agonists (IRAs) affect continuous positive airway pressure (CPAP) use, mortality, and hospitalization in adults with diabetes, obesity, and obstructive sleep apnea?

Population

Adults with diabetes, obesity, and obstructive sleep apnea

Intervention

Incretin receptor agonists (IRAs)

Outcome

Continuous positive airway pressure (CPAP) use, mortality, and hospitalizationhard clinical

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

This cohort study investigates the association of incretin receptor agonists (IRAs) with continuous positive airway pressure (CPAP) use, mortality, and hospitalization among adults with diabetes, obesity, and obstructive sleep apnea.

AIに質問

Bookmark

View Full Paper